skip to main content
Show Results with:

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Le Page, Emmanuelle et al.

The lancet. Volume 386:Issue 9997 (2015); pp 974-981 -- Elsevier

Online access

Searching Remote Databases, Please Wait